|
|
Volumn 175, Issue 9, 2001, Pages 452-453
|
|
Are the new lipid management guidelines good for Australia's health?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTILIPEMIC AGENT;
CHOLESTEROL;
HYPOCHOLESTEROLEMIC AGENT;
LIPID;
LOW DENSITY LIPOPROTEIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
STATIN;
ABORIGINE;
AGE;
AUSTRALIA;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CHOLESTEROL BLOOD LEVEL;
CORONARY ARTERY DILATATION;
COST BENEFIT ANALYSIS;
DIABETES MELLITUS;
DIETITIAN;
DYSLIPIDEMIA;
EDITORIAL;
EVIDENCE BASED MEDICINE;
FINANCIAL MANAGEMENT;
GENERAL PRACTITIONER;
HEALTH;
HEALTH CARE COST;
HEART INFARCTION;
HEART REHABILITATION;
HIGH RISK PATIENT;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERLIPIDEMIA;
LIPID BLOOD LEVEL;
LONG TERM CARE;
MEDICAL DECISION MAKING;
PRACTICE GUIDELINE;
REFERENCE VALUE;
RESOURCE MANAGEMENT;
RESPONSIBILITY;
RISK ASSESSMENT;
RISK BENEFIT ANALYSIS;
|
|
EID: 0035813356
PISSN: 0025729X
EISSN: None
Source Type: Journal
DOI: 10.5694/j.1326-5377.2001.tb143672.x Document Type: Editorial |
|
Times cited : (4)
|
|
References (8)
|
